Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cell conditioned medium for joint disease pain
jRCT1051240054Recruiting
- Sponsor
- EX Clinic
- Start
- Jun 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of human-derived mesenchymal stem cell conditioned medium in knee osteoarthritis (OA), Periarthritis humeroscapularis, hip osteoarthritis and 1 more, sponsored by EX Clinic. Primary endpoint: Pain assessment using visual analogue scale (VAS). Started Jun 2024; status: recruiting.
02
Drugs
human-derived mesenchymal stem cell conditioned medium
03
Conditions
knee osteoarthritis (OA)Periarthritis humeroscapulariship osteoarthritisarthropathy
Beyond the preview
Go deeper on jRCT1051240054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051240054.